Timolol and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Timolol (timolol), especially for people who are female, 60+ old, also take Amlodipine, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Timolol. It is created by eHealthMe based on reports of 9,083 people who have side effects when taking Timolol from the FDA, and is updated regularly.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,435 drugs and 2,773 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 17, 2026

9,083 people reported to have side effects when taking Timolol.
Among them, 36 people (0.4%) have Sinusitis - acute.

Among these 36 people:

What is the gender of people who have Sinusitis - acute when taking Timolol? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Sinusitis - acute when taking Timolol? *

What are other drugs people take besides Timolol? *

What are other side effects people have besides Sinusitis - acute? *

Weight Decreased: 15 people, 41.67%
Headache (pain in head): 12 people, 33.33%
Fatigue (feeling of tiredness): 12 people, 33.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 30.56%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 27.78%
Skin Discoloration: 10 people, 27.78%
Bone Pain: 10 people, 27.78%
Rhinorrhea (watery mucus discharge from the nose): 10 people, 27.78%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 27.78%
Cough: 9 people, 25.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 25.00%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 6 people, 16.67%
Bone Atrophy (decrease in bone mass): 6 people, 16.67%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 6 people, 16.67%
Sleep Disorder: 6 people, 16.67%
Immunodeficiency Common Variable: 5 people, 13.89%
Catarrh (inflammation of mucous membranes, especially of the nose and throat): 5 people, 13.89%
Fallopian Tube Cancer (cancer of fallopian tube): 4 people, 11.11%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Timolol and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timolol:

Timolol (9,142 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Timolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,435 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on timolol (the active ingredients of Timolol) and Timolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.